The advantages of Emperra's ESYSTA System
Por um escritor misterioso
Descrição
The World's First Smart Insulin Pens with Automatic Wireless Data Transfer (868 MHz or Bluetooth®)
EMPERRA Appoints CEO Medical Product Outsourcing
Medical devices, smart drug delivery, wearables and technology for the treatment of Diabetes Mellitus - ScienceDirect
Patients' Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Patients with Type 1 and Type 2 Diabetes
Insulin pen injector - ESYSTA BT - Emperra - reusable
Emperra appoints Bent Johnsen as CEO - PMLiVE
Smart Pens - A Disruptive Force in the Insulin Delivery Market
Robert Bosch Venture Capital GmbH joining Emperra digital diabetes care as a new investor - Medical Design and Outsourcing
PDF) Connected Insulin Pens and Caps: An Expert's Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN)
In-Depth: Five innovators who see the future of connected insulin delivery in pens, not pumps
A Review of Emerging Technologies in Diabetes Management for Multiple-Dose Insulin-Injecting Patients With Type 2 Diabetes Who Self-monitor Blood Glucose - Malgorzata Slugocki, Damian Bialonczyk, Ayşe Elif Özdener, 2019
Technology in the management of type 2 diabetes: Present status and future prospects. - Abstract - Europe PMC
Frontiers The Review of Insulin Pens—Past, Present, and Look to the Future
How the DVG is improving the scalability of Emperra's digital services
Home - Esysta
de
por adulto (o preço varia de acordo com o tamanho do grupo)
